Drug Companies Are Complicating Patents To Monopolize Products
A former chairman of the opioid giant Purdue Pharma has been listed as an inventor on a new patent for a treatment of opioid addiction. Some in the pharmaceutical field are now questioning if this double-dipping in the formation and treatment of opioid addiction is an overstep of patent laws. David Herzberg is an associate professor at […]
Continue Reading